Sun Pharma recalls 55000 bottles of generic drug to treat gout from American market
The affected lot was produced at Sun Pharma's Dadra-based plant for Memphis-based Northstar Rx LLC, the US regulator noted.
Mumbai: Drug major Sun Pharma is recalling around 55,000 bottles of a generic medication to treat gout from the American market due to manufacturing practices norms deviations, according to the US health regulator.The New Jersey-based unit of the Mumbai-based drug major is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, US Food and Drug Administration (USFDA) said in its...
Mumbai: Drug major Sun Pharma is recalling around 55,000 bottles of a generic medication to treat gout from the American market due to manufacturing practices norms deviations, according to the US health regulator.
Read also: Sun Pharma unit recalls over 54000 bottles of Mesalamine ER capsules in US
Original news source: https://www.ptinews.com/story/business/sun-pharma-recalls-55-000-bottles-of-generic-drug-from-us-market-due-to-manufacturing-norms-violation/1347602
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd